Ervogastat (PF-06865571), a systemically acting diacylglycerol acyltransferase (DGAT2) inhibitor that has advanced into clinical trials for the treatment of non-alcoholic steatohepatitis (NASH) with liver fibrosis.
武汉永璨生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
武汉永璨生物